Muenz; Markus
Patent Applications and Registrations
Patent applications and USPTO patent grants for Muenz; Markus.The latest application filed is for "method for treating glioblastoma or glioma with anitbody constructs egfrviii and cd3".
- Muenz; Markus - Munich DE
- MUENZ; Markus - Lenggries DE
- Muenz; Markus - Muenchen DE
- Muenz; Markus - Wolfratshausen DE
- Muenz; Markus - Greiling DE
| Patent | Date |
|---|---|
| Method For Treating Glioblastoma Or Glioma With Anitbody Constructs Egfrviii And Cd3 App 20220064308 - Raum; Tobias ; et al. | 2022-03-03 |
| Mageb2 Binding Constructs App 20220017636 - FOLTZ; Ian Nevin ; et al. | 2022-01-20 |
| Method for treating glioblastoma or glioma with antibody constructs for EGFRVIII and CD3 Grant 11,155,629 - Raum , et al. October 26, 2 | 2021-10-26 |
| Antibody Constructs For Egfrviii And Cd3 App 20200140558 - Raum; Tobias ; et al. | 2020-05-07 |
| Antibody constructs for EGFRVIII and CD3 Grant 10,519,241 - Raum , et al. Dec | 2019-12-31 |
| Antibody Constructs For Egfrviii And Cd3 App 20170029512 - Raum; Tobias ; et al. | 2017-02-02 |
| Antibody constructs for influenza M2 and CD3 Grant 9,505,849 - Kufer , et al. November 29, 2 | 2016-11-29 |
| Antibody Constructs For Influenza M2 And Cd3 App 20160039948 - Kufer; Peter ; et al. | 2016-02-11 |
| Long Life Polypeptide Binding Molecules App 20150037334 - Kufer; Peter ; et al. | 2015-02-05 |
| Specific Protease Inhibitors And Their Use In Cancer Therapy App 20100226922 - Maetzel; Dorothea ; et al. | 2010-09-09 |
| Squamous cell carcinoma antigens and use therefor App 20070009501 - Gires; Oliver ; et al. | 2007-01-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 